Zhou, Xi
Ye, Qinghao
Yang, Xiaolin
Chen, Jiakun
Ma, Haiqin
Xia, Jun
Del Ser, Javier
Yang, Guang https://orcid.org/0000-0001-7344-7733
Funding for this research was provided by:
Shenzhen International Cooperation Foundation (GJHZ20180926165402083)
British Heart Foundation (TG/18/5/34111)
British Heart Foundation (PG/16/78/32402)
Hangzhou Economic and Technological Development Area Strategical Grant (Imperial Institute of Advanced Technology)
Innovative Medicines Initiative (H2020-JTI-IMI2 101005122)
Horizon 2020 (H2020-SC1-FA-DTS-2019-1 952172)
UK Research and Innovation (MR/V023799/1)
Eusko Jaurlaritza (IT1294-19)
Article History
Received: 11 August 2021
Accepted: 31 January 2022
First Online: 24 February 2022
Declarations
:
: There are no potential competing interests in our paper. And all authors have seen the manuscript and approved to submit to your journal. We confirm that the content of the manuscript has not been published or submitted for publication elsewhere.
: This study passed the ethical approval of The First Affiliated Hospital of Shenzhen University's bioethics committee (approval no. KS20190114001), and the researchers all signed the informed consent form.
: Informed consent was obtained from all individual participants included in the study.
: All authors have read and agreed to the published version of the manuscript.